Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Fatty Liver | 5 | 2021 | 299 | 1.90 | Why? |
Insulin Resistance | 8 | 2021 | 669 | 1.14 | Why? |
Body Fat Distribution | 1 | 2021 | 25 | 0.92 | Why? |
Immunoglobulin lambda-Chains | 1 | 2019 | 6 | 0.81 | Why? |
Immunoglobulin kappa-Chains | 1 | 2019 | 12 | 0.81 | Why? |
Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2018 | 2 | 0.78 | Why? |
Diglycerides | 1 | 2018 | 32 | 0.77 | Why? |
Hepatic Stellate Cells | 1 | 2018 | 35 | 0.76 | Why? |
Immunoglobulin Light Chains | 1 | 2019 | 62 | 0.75 | Why? |
Paraproteinemias | 1 | 2019 | 61 | 0.75 | Why? |
Fetuin-B | 1 | 2017 | 1 | 0.74 | Why? |
alpha-2-HS-Glycoprotein | 1 | 2017 | 25 | 0.71 | Why? |
Mitosis | 1 | 2017 | 43 | 0.69 | Why? |
Blood Preservation | 1 | 2019 | 191 | 0.69 | Why? |
Lipase | 1 | 2018 | 153 | 0.66 | Why? |
Blood Cells | 1 | 2017 | 104 | 0.64 | Why? |
Liver | 7 | 2021 | 4007 | 0.61 | Why? |
Cryopreservation | 1 | 2019 | 464 | 0.58 | Why? |
Everolimus | 1 | 2017 | 215 | 0.57 | Why? |
Hemostasis | 1 | 2021 | 811 | 0.56 | Why? |
Insulin | 7 | 2018 | 1316 | 0.48 | Why? |
Hematologic Tests | 1 | 2017 | 521 | 0.48 | Why? |
Diabetes Mellitus, Type 2 | 7 | 2021 | 6166 | 0.44 | Why? |
Glycated Hemoglobin A | 2 | 2018 | 1316 | 0.41 | Why? |
Polymorphism, Single Nucleotide | 4 | 2019 | 3607 | 0.39 | Why? |
Infant, Premature | 4 | 2018 | 883 | 0.37 | Why? |
Non-alcoholic Fatty Liver Disease | 4 | 2019 | 907 | 0.37 | Why? |
Reticulocytes | 2 | 2018 | 55 | 0.36 | Why? |
Membrane Proteins | 1 | 2018 | 1733 | 0.35 | Why? |
Food, Fortified | 2 | 2018 | 43 | 0.35 | Why? |
Blood Coagulation Tests | 3 | 2017 | 855 | 0.35 | Why? |
Dabigatran | 3 | 2017 | 204 | 0.33 | Why? |
Glucose Tolerance Test | 5 | 2019 | 238 | 0.33 | Why? |
Diabetes Mellitus | 2 | 2020 | 8207 | 0.32 | Why? |
Serologic Tests | 1 | 2020 | 4359 | 0.30 | Why? |
Blood Glucose | 8 | 2019 | 3642 | 0.30 | Why? |
Hypothalamus | 2 | 2017 | 58 | 0.30 | Why? |
Hospitals, University | 1 | 2017 | 4173 | 0.28 | Why? |
Acetaminophen | 2 | 2017 | 326 | 0.27 | Why? |
Energy Metabolism | 2 | 2018 | 451 | 0.26 | Why? |
Liver Failure, Acute | 2 | 2017 | 279 | 0.26 | Why? |
Glucose | 2 | 2018 | 573 | 0.25 | Why? |
Epitopes, T-Lymphocyte | 3 | 2021 | 2262 | 0.22 | Why? |
Overweight | 2 | 2018 | 916 | 0.22 | Why? |
Thrombin Time | 2 | 2017 | 46 | 0.22 | Why? |
Protein S | 1 | 2021 | 150 | 0.21 | Why? |
Protein C | 1 | 2021 | 141 | 0.21 | Why? |
Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2019 | 4 | 0.21 | Why? |
Latex | 1 | 2019 | 9 | 0.20 | Why? |
Lipogenesis | 1 | 2019 | 49 | 0.20 | Why? |
Hypoglycemic Agents | 3 | 2018 | 2165 | 0.19 | Why? |
Eryptosis | 1 | 2018 | 3 | 0.19 | Why? |
G-Protein-Coupled Receptor Kinase 5 | 1 | 2018 | 3 | 0.19 | Why? |
T-Lymphocytes | 3 | 2021 | 6670 | 0.19 | Why? |
Drug Monitoring | 2 | 2017 | 1408 | 0.19 | Why? |
Cell Line, Transformed | 1 | 2018 | 87 | 0.19 | Why? |
Biomarkers, Tumor | 2 | 2019 | 1314 | 0.19 | Why? |
Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.19 | Why? |
Islet Amyloid Polypeptide | 1 | 2018 | 7 | 0.19 | Why? |
46, XX Disorders of Sex Development | 1 | 2017 | 4 | 0.19 | Why? |
Mullerian Ducts | 1 | 2017 | 6 | 0.18 | Why? |
Bottle Feeding | 1 | 2018 | 28 | 0.18 | Why? |
Fluorouracil | 1 | 2019 | 169 | 0.18 | Why? |
Partial Thromboplastin Time | 2 | 2017 | 436 | 0.18 | Why? |
Ceramides | 1 | 2018 | 80 | 0.18 | Why? |
Immunosuppressive Agents | 1 | 2017 | 6331 | 0.18 | Why? |
Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2017 | 25 | 0.18 | Why? |
Phosphatidylserines | 1 | 2018 | 99 | 0.18 | Why? |
Prothrombin Time | 2 | 2017 | 434 | 0.18 | Why? |
Infant, Very Low Birth Weight | 1 | 2018 | 62 | 0.18 | Why? |
Prediabetic State | 2 | 2017 | 200 | 0.18 | Why? |
Ovarian Reserve | 1 | 2017 | 45 | 0.18 | Why? |
Neostriatum | 1 | 2017 | 6 | 0.17 | Why? |
Anti-Mullerian Hormone | 1 | 2017 | 35 | 0.17 | Why? |
Automation | 1 | 2020 | 429 | 0.17 | Why? |
Cardiovascular Abnormalities | 1 | 2018 | 72 | 0.17 | Why? |
Ovulation Induction | 1 | 2017 | 58 | 0.17 | Why? |
Gluconeogenesis | 1 | 2017 | 41 | 0.17 | Why? |
Phosphates | 1 | 2018 | 135 | 0.17 | Why? |
Ethanolamines | 1 | 2018 | 71 | 0.17 | Why? |
Uterus | 1 | 2017 | 98 | 0.17 | Why? |
Dietary Proteins | 1 | 2018 | 112 | 0.17 | Why? |
Term Birth | 1 | 2017 | 56 | 0.17 | Why? |
Jejunum | 1 | 2017 | 82 | 0.17 | Why? |
Amyloid | 1 | 2018 | 156 | 0.17 | Why? |
Carotid Intima-Media Thickness | 1 | 2018 | 179 | 0.17 | Why? |
Mass Screening | 1 | 2017 | 8005 | 0.17 | Why? |
Thinness | 1 | 2017 | 99 | 0.16 | Why? |
Rivaroxaban | 2 | 2017 | 467 | 0.16 | Why? |
Protein Stability | 1 | 2019 | 756 | 0.16 | Why? |
Congenital Abnormalities | 1 | 2017 | 170 | 0.15 | Why? |
Fibrinolysis | 1 | 2021 | 521 | 0.15 | Why? |
Albuminuria | 1 | 2017 | 164 | 0.15 | Why? |
Nasal Sprays | 1 | 2018 | 234 | 0.15 | Why? |
Amyloidosis | 1 | 2018 | 178 | 0.15 | Why? |
Receptors, Antigen, T-Cell | 1 | 2021 | 760 | 0.15 | Why? |
Intra-Abdominal Fat | 1 | 2018 | 227 | 0.15 | Why? |
Receptors, Androgen | 1 | 2017 | 212 | 0.15 | Why? |
Factor Xa Inhibitors | 2 | 2017 | 490 | 0.15 | Why? |
RNA, Messenger | 3 | 2018 | 5131 | 0.15 | Why? |
Thrombelastography | 1 | 2021 | 627 | 0.14 | Why? |
Prostate | 1 | 2017 | 283 | 0.14 | Why? |
Genetic Association Studies | 1 | 2018 | 559 | 0.14 | Why? |
Parasympathetic Nervous System | 1 | 2014 | 16 | 0.14 | Why? |
Neuroprotective Agents | 1 | 2018 | 240 | 0.14 | Why? |
Genetic Predisposition to Disease | 3 | 2018 | 4027 | 0.14 | Why? |
Rectal Neoplasms | 1 | 2019 | 278 | 0.14 | Why? |
Pyridones | 2 | 2017 | 738 | 0.14 | Why? |
Fetal Blood | 2 | 2018 | 573 | 0.14 | Why? |
Immunologic Memory | 3 | 2021 | 3362 | 0.14 | Why? |
Blood Cell Count | 2 | 2017 | 1101 | 0.14 | Why? |
Coronaviridae | 1 | 2021 | 923 | 0.14 | Why? |
Catechin | 1 | 2018 | 244 | 0.14 | Why? |
Receptors, Urokinase Plasminogen Activator | 1 | 2017 | 252 | 0.13 | Why? |
Cholesterol, LDL | 1 | 2018 | 499 | 0.13 | Why? |
Pancreas | 1 | 2018 | 398 | 0.13 | Why? |
Quality Control | 1 | 2018 | 628 | 0.13 | Why? |
Hepcidins | 1 | 2014 | 97 | 0.13 | Why? |
Hemoglobins | 2 | 2017 | 958 | 0.13 | Why? |
Enteral Nutrition | 1 | 2017 | 320 | 0.13 | Why? |
Uric Acid | 1 | 2017 | 285 | 0.13 | Why? |
RNA, Small Interfering | 1 | 2018 | 817 | 0.13 | Why? |
Chromatography, Liquid | 1 | 2017 | 640 | 0.13 | Why? |
Bone Marrow | 1 | 2017 | 492 | 0.13 | Why? |
Mice, Knockout | 1 | 2018 | 1815 | 0.13 | Why? |
Diabetes, Gestational | 1 | 2018 | 426 | 0.12 | Why? |
Hemodynamics | 2 | 2018 | 1562 | 0.12 | Why? |
Parturition | 1 | 2017 | 514 | 0.12 | Why? |
Cross Reactions | 2 | 2021 | 4374 | 0.12 | Why? |
Humans | 45 | 2021 | 930598 | 0.12 | Why? |
Biopsy | 2 | 2018 | 2811 | 0.12 | Why? |
Obesity | 3 | 2019 | 7388 | 0.12 | Why? |
Chemokines | 1 | 2018 | 1095 | 0.12 | Why? |
Anemia, Iron-Deficiency | 1 | 2014 | 210 | 0.11 | Why? |
Central Nervous System | 1 | 2017 | 701 | 0.11 | Why? |
Creatinine | 1 | 2018 | 1443 | 0.11 | Why? |
Antibodies, Viral | 3 | 2021 | 51949 | 0.11 | Why? |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 526 | 0.11 | Why? |
Kidney Failure, Chronic | 2 | 2018 | 3222 | 0.11 | Why? |
Tandem Mass Spectrometry | 1 | 2017 | 1031 | 0.11 | Why? |
Biomarkers | 6 | 2021 | 23361 | 0.10 | Why? |
Magnetic Resonance Imaging | 4 | 2021 | 6551 | 0.10 | Why? |
Phenotype | 2 | 2018 | 4037 | 0.10 | Why? |
Leukemia, Myeloid, Acute | 1 | 2017 | 676 | 0.10 | Why? |
Pyrazoles | 2 | 2017 | 1791 | 0.10 | Why? |
Male | 26 | 2021 | 367725 | 0.10 | Why? |
Anemia | 1 | 2017 | 789 | 0.10 | Why? |
Up-Regulation | 1 | 2017 | 2249 | 0.10 | Why? |
Female | 25 | 2021 | 380317 | 0.10 | Why? |
Heart Rate | 2 | 2018 | 1527 | 0.09 | Why? |
Proteins | 1 | 2017 | 921 | 0.09 | Why? |
Diagnostic Imaging | 1 | 2017 | 1044 | 0.09 | Why? |
Middle Aged | 17 | 2021 | 270681 | 0.09 | Why? |
Case-Control Studies | 5 | 2018 | 17671 | 0.09 | Why? |
Cohort Studies | 4 | 2021 | 36005 | 0.09 | Why? |
Peptides | 1 | 2020 | 2513 | 0.09 | Why? |
Reproducibility of Results | 3 | 2020 | 11304 | 0.09 | Why? |
Antioxidants | 1 | 2018 | 1593 | 0.09 | Why? |
Aged | 13 | 2021 | 215776 | 0.09 | Why? |
ROC Curve | 1 | 2020 | 6024 | 0.09 | Why? |
Placenta | 1 | 2018 | 1531 | 0.09 | Why? |
Glycolysis | 2 | 2019 | 208 | 0.09 | Why? |
Heart Transplantation | 1 | 2017 | 1293 | 0.08 | Why? |
Glucose Clamp Technique | 2 | 2017 | 39 | 0.08 | Why? |
New York City | 1 | 2020 | 7432 | 0.08 | Why? |
Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
Hospitalization | 1 | 2017 | 54280 | 0.08 | Why? |
Brain | 3 | 2018 | 5133 | 0.08 | Why? |
Anticoagulants | 2 | 2017 | 9563 | 0.08 | Why? |
Functional Neuroimaging | 2 | 2017 | 86 | 0.07 | Why? |
Adult | 18 | 2021 | 244371 | 0.07 | Why? |
Triglycerides | 2 | 2019 | 478 | 0.07 | Why? |
Dietary Supplements | 1 | 2018 | 2251 | 0.07 | Why? |
Sleep | 1 | 2018 | 2695 | 0.07 | Why? |
Immunoassay | 2 | 2021 | 4485 | 0.07 | Why? |
Prostatic Neoplasms | 1 | 2017 | 1637 | 0.07 | Why? |
Germany | 2 | 2017 | 9196 | 0.07 | Why? |
Mice | 3 | 2019 | 21357 | 0.07 | Why? |
Antithrombins | 2 | 2017 | 353 | 0.07 | Why? |
Blood Coagulation Disorders | 1 | 2017 | 2040 | 0.06 | Why? |
Time Factors | 4 | 2021 | 31397 | 0.06 | Why? |
Point-of-Care Systems | 1 | 2017 | 2955 | 0.06 | Why? |
Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.06 | Why? |
Fasting | 2 | 2018 | 555 | 0.06 | Why? |
Oxygen Consumption | 2 | 2017 | 711 | 0.06 | Why? |
Neutrophils | 1 | 2019 | 5476 | 0.06 | Why? |
Weight Gain | 2 | 2017 | 552 | 0.06 | Why? |
Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.06 | Why? |
Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
Administration, Intranasal | 2 | 2018 | 1132 | 0.06 | Why? |
Lipids | 2 | 2018 | 1079 | 0.06 | Why? |
Mice, Transgenic | 2 | 2019 | 2739 | 0.05 | Why? |
Peptide Mapping | 1 | 2021 | 112 | 0.05 | Why? |
Renal Dialysis | 1 | 2018 | 4358 | 0.05 | Why? |
Gestational Age | 2 | 2018 | 1488 | 0.05 | Why? |
Phosphoproteins | 2 | 2021 | 4346 | 0.05 | Why? |
Specimen Handling | 1 | 2018 | 6190 | 0.05 | Why? |
Animals | 6 | 2019 | 78931 | 0.05 | Why? |
Young Adult | 7 | 2021 | 93724 | 0.05 | Why? |
Gene Knock-In Techniques | 1 | 2019 | 124 | 0.05 | Why? |
Chemoradiotherapy, Adjuvant | 1 | 2019 | 69 | 0.05 | Why? |
Acoustic Stimulation | 1 | 2018 | 20 | 0.05 | Why? |
Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
Sleep Stages | 1 | 2018 | 52 | 0.05 | Why? |
Cytochrome P450 Family 7 | 1 | 2017 | 1 | 0.05 | Why? |
Calorimetry, Indirect | 1 | 2018 | 49 | 0.05 | Why? |
Predictive Value of Tests | 3 | 2021 | 9537 | 0.05 | Why? |
Cholestanetriol 26-Monooxygenase | 1 | 2017 | 12 | 0.05 | Why? |
Chromogenic Compounds | 1 | 2017 | 10 | 0.05 | Why? |
Receptor, Insulin | 1 | 2017 | 18 | 0.05 | Why? |
Fatty Acids, Nonesterified | 1 | 2018 | 60 | 0.05 | Why? |
Receptor, IGF Type 1 | 1 | 2017 | 24 | 0.05 | Why? |
Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
Estrogen Receptor beta | 1 | 2017 | 14 | 0.05 | Why? |
Milk, Human | 2 | 2018 | 956 | 0.05 | Why? |
Glutamate Carboxypeptidase II | 1 | 2017 | 24 | 0.05 | Why? |
Proinsulin | 1 | 2017 | 9 | 0.05 | Why? |
Reticulocyte Count | 1 | 2017 | 7 | 0.05 | Why? |
Steroid Hydroxylases | 1 | 2017 | 23 | 0.05 | Why? |
Diet, High-Fat | 1 | 2019 | 161 | 0.04 | Why? |
Swine | 2 | 2017 | 3352 | 0.04 | Why? |
Dose-Response Relationship, Drug | 2 | 2018 | 3776 | 0.04 | Why? |
Hyperandrogenism | 1 | 2017 | 36 | 0.04 | Why? |
HLA-DR Antigens | 1 | 2020 | 563 | 0.04 | Why? |
Deuterium | 1 | 2017 | 21 | 0.04 | Why? |
Anthropometry | 1 | 2018 | 233 | 0.04 | Why? |
Ki-67 Antigen | 1 | 2017 | 139 | 0.04 | Why? |
Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 198 | 0.04 | Why? |
Aged, 80 and over | 5 | 2021 | 88759 | 0.04 | Why? |
Lysophospholipids | 1 | 2018 | 74 | 0.04 | Why? |
Proton Magnetic Resonance Spectroscopy | 1 | 2018 | 159 | 0.04 | Why? |
Intracranial Pressure | 1 | 2017 | 90 | 0.04 | Why? |
Sphingosine | 1 | 2018 | 101 | 0.04 | Why? |
Kallikreins | 1 | 2017 | 158 | 0.04 | Why? |
Molecular Conformation | 1 | 2018 | 374 | 0.04 | Why? |
Risk Factors | 3 | 2021 | 71621 | 0.04 | Why? |
Norepinephrine | 1 | 2017 | 152 | 0.04 | Why? |
Polysomnography | 1 | 2018 | 296 | 0.04 | Why? |
Kidney Transplantation | 1 | 2017 | 5397 | 0.04 | Why? |
Antigens, Surface | 1 | 2017 | 181 | 0.04 | Why? |
Prostate-Specific Antigen | 1 | 2017 | 213 | 0.04 | Why? |
Trophoblasts | 1 | 2018 | 237 | 0.04 | Why? |
Programmed Cell Death 1 Receptor | 1 | 2021 | 724 | 0.04 | Why? |
Immunodominant Epitopes | 1 | 2021 | 813 | 0.04 | Why? |
Blood Flow Velocity | 1 | 2017 | 193 | 0.04 | Why? |
Solubility | 1 | 2017 | 382 | 0.04 | Why? |
Erythrocyte Indices | 1 | 2017 | 207 | 0.04 | Why? |
Neoadjuvant Therapy | 1 | 2019 | 554 | 0.04 | Why? |
Genotype | 2 | 2018 | 4697 | 0.04 | Why? |
Histocompatibility Antigens Class I | 1 | 2020 | 624 | 0.04 | Why? |
Pandemics | 2 | 2020 | 389249 | 0.04 | Why? |
Follow-Up Studies | 3 | 2019 | 17020 | 0.04 | Why? |
Hemofiltration | 1 | 2017 | 155 | 0.04 | Why? |
Polycystic Ovary Syndrome | 1 | 2017 | 151 | 0.04 | Why? |
Infant, Newborn | 4 | 2018 | 23105 | 0.04 | Why? |
Observer Variation | 1 | 2017 | 622 | 0.04 | Why? |
Prevalence | 1 | 2017 | 25773 | 0.04 | Why? |
Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
Inflammation Mediators | 2 | 2018 | 2654 | 0.04 | Why? |
Endpoint Determination | 1 | 2017 | 344 | 0.04 | Why? |
Lactic Acid | 1 | 2018 | 393 | 0.04 | Why? |
Body Mass Index | 2 | 2018 | 4306 | 0.04 | Why? |
Portal Vein | 1 | 2017 | 193 | 0.03 | Why? |
Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
Body Composition | 1 | 2018 | 414 | 0.03 | Why? |
Occupations | 1 | 2020 | 733 | 0.03 | Why? |
Disease-Free Survival | 1 | 2019 | 1654 | 0.03 | Why? |
Stroke | 1 | 2017 | 8839 | 0.03 | Why? |
Graft Survival | 1 | 2017 | 587 | 0.03 | Why? |
Enterococcus faecalis | 1 | 2014 | 126 | 0.03 | Why? |
Ultrasonography, Doppler | 1 | 2017 | 406 | 0.03 | Why? |
Cell Membrane | 1 | 2018 | 743 | 0.03 | Why? |
Antigens, CD | 1 | 2018 | 984 | 0.03 | Why? |
Infant, Low Birth Weight | 1 | 2014 | 243 | 0.03 | Why? |
Lipid Metabolism | 1 | 2017 | 572 | 0.03 | Why? |
Birth Weight | 1 | 2014 | 250 | 0.03 | Why? |
Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
Neoplasms | 1 | 2021 | 17251 | 0.03 | Why? |
Cattle | 1 | 2017 | 1336 | 0.03 | Why? |
Fetal Growth Retardation | 1 | 2014 | 217 | 0.03 | Why? |
Neoplasm Staging | 1 | 2019 | 1999 | 0.03 | Why? |
Prospective Studies | 4 | 2018 | 43301 | 0.03 | Why? |
Lymphocyte Activation | 1 | 2021 | 2742 | 0.03 | Why? |
Body Weight | 1 | 2017 | 1074 | 0.03 | Why? |
Reference Values | 1 | 2014 | 795 | 0.03 | Why? |
Electroencephalography | 1 | 2018 | 1242 | 0.03 | Why? |
Cerebrovascular Circulation | 1 | 2014 | 340 | 0.03 | Why? |
Adolescent | 2 | 2021 | 86841 | 0.03 | Why? |
Gram-Positive Bacterial Infections | 1 | 2014 | 323 | 0.03 | Why? |
Disease Models, Animal | 2 | 2019 | 10998 | 0.03 | Why? |
Infusions, Intravenous | 1 | 2014 | 1224 | 0.03 | Why? |
Drug Overdose | 1 | 2017 | 583 | 0.02 | Why? |
Convalescence | 1 | 2021 | 2829 | 0.02 | Why? |
Plant Extracts | 1 | 2021 | 1514 | 0.02 | Why? |
Immunity | 1 | 2021 | 2651 | 0.02 | Why? |
Cognition | 1 | 2018 | 1394 | 0.02 | Why? |
Sensitivity and Specificity | 2 | 2021 | 22971 | 0.02 | Why? |
Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
Lymphocyte Count | 1 | 2019 | 4758 | 0.02 | Why? |
Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
Monitoring, Physiologic | 1 | 2017 | 1956 | 0.02 | Why? |
Blood Pressure | 1 | 2017 | 2198 | 0.02 | Why? |
CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
Thrombolytic Therapy | 1 | 2017 | 2218 | 0.02 | Why? |
Pregnancy | 2 | 2018 | 23879 | 0.02 | Why? |
Ferritins | 1 | 2014 | 2055 | 0.02 | Why? |
Delivery, Obstetric | 1 | 2014 | 1292 | 0.02 | Why? |
Prognosis | 2 | 2018 | 32490 | 0.02 | Why? |
Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
Point-of-Care Testing | 1 | 2017 | 2782 | 0.02 | Why? |
Clinical Decision-Making | 1 | 2017 | 3755 | 0.02 | Why? |
Models, Molecular | 1 | 2018 | 7616 | 0.02 | Why? |
Thrombocytopenia | 1 | 2017 | 2093 | 0.02 | Why? |
Multivariate Analysis | 1 | 2014 | 5440 | 0.02 | Why? |
Odds Ratio | 1 | 2014 | 5861 | 0.01 | Why? |
Emergencies | 1 | 2017 | 4095 | 0.01 | Why? |
Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
Treatment Outcome | 2 | 2019 | 51732 | 0.01 | Why? |
Protein Binding | 1 | 2018 | 11430 | 0.01 | Why? |
Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.01 | Why? |
Logistic Models | 1 | 2014 | 9089 | 0.01 | Why? |
Clinical Trials as Topic | 1 | 2017 | 7330 | 0.01 | Why? |
Sepsis | 1 | 2014 | 3517 | 0.01 | Why? |
Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
Infant | 1 | 2017 | 30274 | 0.01 | Why? |
Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
Age Factors | 1 | 2014 | 21039 | 0.01 | Why? |
Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
Child | 1 | 2021 | 70012 | 0.01 | Why? |